hsa-miR-20a

ncRNA information

ncRNA name

hsa-miR-20a

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

Yes

Biomarker application

Treatment

Upstream regulatory factors

Not available

Downstream target

BNIP2

Cancer information

Cancer name

Colorectal Adenocarcinoma

Cancer site

Colon, Rectum, and Anus

Treatment information

Treatment type

Chemotherapy

Drug

Fluorouracil/Oxaliplatin/Teniposide

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

MiR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines.

Tissue resource

colorectal cancer cell lines SW620

colorectal cancer cell lines SW480

Experiment

qRT-PCR,Western blot


Institute

Country

Continent